Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 1]
This document reports the completion of a Phase 1 trial evaluating taurolidine in patients with recurrent ovarian epithelial cancer, fallopi…
-
CLINICAL_TRIALS trial_result · 2013-06-13Clinical Trial Update: Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer [Phase 2]
This clinical trial update indicates the Phase 2 study of sorafenib tosylate plus gemcitabine hydrochloride in recurrent ovarian epithelial …
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer [Phase 1]
A Phase 1 trial evaluating the combination of gemcitabine and topotecan for refractory or recurrent ovarian cancer, fallopian tube cancer, o…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating liposomal doxorubicin and etoposide in recurrent or persistent ovarian, fallopian tube, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2013-06-07Clinical Trial Update: Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer [Phase 2]
Phase 2 trial of an investigational Tarix Pharmaceuticals agent to reduce chemotherapy-induced thrombocytopenia in patients with ovarian, fa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating a monoclonal antibody vaccine therapy for ovarian epithelial, fallopian tube, and primary peritoneal cancers has co…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women [Phase 2]
A Phase 2 trial evaluating pazopanib monotherapy after first-line chemotherapy in Asian women with ovarian, fallopian tube, or primary perit…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial (CT-2103) evaluated CT-2103 in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, or prima…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating the combination of gemcitabine and cisplatin for patients with recurrent or platinum-refractory ovarian ca…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer [Phase 3]
This clinical trial update reports the completion of a Phase 3 study evaluating paclitaxel plus cisplatin in patients with stage III or IV o…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer [Phase 1]
This update summarizes a Phase 1 clinical trial evaluating paclitaxel in patients with recurrent or persistent ovarian cancer or primary per…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 trial evaluating the combination of topotecan and etoposide in patients with recurrent ovarian, fallopian tube, or primary peritonea…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer [Phase 1]
A Phase 1 study of a combination chemotherapy regimen for stage III/IV ovarian epithelial cancer or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]
This is a Phase 1 study of a combination chemotherapy regimen in patients with untreated ovarian cancer, fallopian tube cancer, or primary p…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer [Phase 3]
A Phase 3 trial evaluating a combination chemotherapy regimen for stage III epithelial ovarian cancer and primary peritoneal cancer has comp…
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: Abraxane/Bevacizumab [Phase 2]
A Phase 2 trial of Abraxane (nab-paclitaxel) in combination with Bevacizumab for ovarian cancer and peritoneal cancer was terminated, with r…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating cisplatin in combination with flavopiridol for advanced or recurrent ovarian epithelial cancer and recurrent primar…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating the combination chemotherapy plus peripheral stem cell transplantation in patients with Stage III/IV ovarian canc…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of docetaxel in patients with recurrent or refractory ovarian cancer or primary peritoneal cancer; the study status is termina…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer [Phase 2]
A Phase 2 trial evaluating capecitabine for recurrent ovarian epithelial cancer or primary peritoneal cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer [Phase 2]
Phase 2 trial of amifostine for gynecologic cancers has been terminated (including ovarian, primary peritoneal, fallopian tube, cervical, ut…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel for ovarian cancer and primary peritoneal cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Depsipeptide (Romidepsin) in Treating Patients With Recurrent Ovarian Epithelial or Peritoneal Cavity Cancer [Phase 2]
A National Cancer Institute-sponsored Phase 2 trial of romidepsin (depsipeptide) for recurrent ovarian epithelial cancer and primary periton…
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer [Phase 1]
Phase I clinical trial evaluating an autologous dendritic cell vaccine in patients with recurrent ovarian cancer or primary peritoneal cance…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
A phase 2 clinical trial evaluating imatinib mesylate for persistent or recurrent ovarian epithelial cancer or primary peritoneal cancer has…